Physician profile
Tracy Ho
NPI 1215212493
$4,387.52
in general payments reported to CMS, 2019-2025
16 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $400 · 2021: $924 · 2022: $491 · 2023: $1,215 · 2024: $649 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,159.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $950.12 | 2019-2023 | Myday Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $805.37 | 2022-2025 | Infuse, Biotrue One Day, Xiidra |
| Alcon Vision LLC | $732.94 | 2019-2024 | Dailies Total1 |
| Abbvie INC. | $389.64 | 2022-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $285.79 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $263.45 | 2023-2025 | Acuvue |
| Rxsight INC | $205.37 | 2022-2023 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal) |
| Biotissue Holdings INC. | $127.04 | 2024 | |
| Glaukos Corporation | $120.20 | 2022 | |
| Lkc Technologies, INC. | $110.38 | 2024 | |
| Apellis Pharmaceuticals, INC. | $108.75 | 2023 | Syfovre |
| Carl Zeiss Meditec USA, INC. | $95.05 | 2025 | Cirrus Hd-Oct |
| Abb Con-Cise Optical Group LLC | $84.08 | 2021 | |
| Optos, INC. | $69.47 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $21.07 | 2025 | Xdemvy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $18.80 | 2024 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.